Nodenza Venture Partners to attend TRS and NYS Emerging Manager Conferences in February 2026

  • Article
  • Feb 3, 2026
  • 1 Min Read

Written By Nodenza

Nodenza Venture Partners to attend TRS and NYS Emerging Manager Conferences in February 2026

Austin, TX & Albany, NY – February 2026 – Nodenza Venture Partners (“Nodenza”) will participate in two institutional emerging manager forums this month:

The firm will engage with public pension allocators evaluating differentiated healthcare and life sciences investment strategies.
Nodenza’s approach combines clinical proof-of-concept innovation (IND through Phase 2) with product launch assets transitioning toward commercialization, providing exposure to both scientific value creation and market readiness.

Institutional stakeholders are invited to connect with the Nodenza team during the events.

Contacts

Nodenza Venture Partner

Ross Morton, Managing Partner

Notes For Editors

About Nodenza Venture Partners

Nodenza Venture Partners provides investment and operational support to clinical proof-of-concept and product launch biotech and medtech companies seeking to bring exceptional benefits to patients. Our bi-modal investment strategy combines early-stage opportunities – advancing new treatment modalities through active IND to phase 2 – with commercial targets supporting their transition from scientific to commercial companies delivering strong upside potential. Established by a team of experienced life sciences entrepreneurs, founders and leaders, our approach leverages Nodenza’s extensive expertise in the creation and growth of new companies, as well as late-stage product development and launch.